Skip to content

Clinical trials

Completed beta-Thalassemia trials in Lebanon

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Status: Completed Country / region: Lebanon Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20091
20121
20141
20162
20171
20181
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Novartis Pharmaceuticals3
Boston University1
Forma Therapeutics, Inc.1
HemaQuest Pharmaceuticals Inc.1
Hoffmann-La Roche1
Novartis1
Vifor (International) Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia12
Thalassemia5
Hemosiderosis2
Iron Overload2
alpha-Thalassemia2
Anemia1
Anemia, Hemolytic1
Anemia, Sickle Cell1
Genetic Diseases, Inborn1
Hematologic Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.